Twenty-four mini-pool HCV RNA screening outside a blood transfusion setting: Results of a 2-year prospective study

Journal of Virological Methods

Volumn 140, Issue 1-2, 2007, Pages 218-221

  Seme, Katja ^a   Močilnik, Tina ^a   Fujs, Kristina ^a   Babič, Dunja Z ^a   Todorović, Aleksandra ^b   Fras Stefan, Tamara ^b   Poljak, Mario ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b Primary Health Care Center   (Slovenia)

Author keywords

HCV; Hepatitis C; Intravenous drug users; PCR; Screening

Indexed keywords

VIRUS RNA;

ARTICLE; AUTOMATION; BLOOD TRANSFUSION; CLINICAL ARTICLE; COST BENEFIT ANALYSIS; DIAGNOSTIC PROCEDURE; FOLLOW UP; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; LABORATORY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; SCREENING; SEROCONVERSION; SERUM; VIRUS DETECTION; VIRUS INFECTION;

BLOOD DONORS; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HUMANS; MASS SCREENING; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RNA, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS; VIRAL LOAD;

HEPATITIS C VIRUS;

EID: 33846625829     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2006.11.006     Document Type: Article

References (20)

1. Alvarez do Barrio M., Gonzalez Diez R., Hernandez Sanchez J.M., and Oyonarte Gomez S. Residual risk of transfusion-transmitted viral infections in Spain, 1997-2002, and impact of nucleic acid testing. Euro Surveill. 10 (2005) 20-22
2. Aswad S., Khan N.S., Comanor L., Chinchilla C., Corado L., Mone T., Mendez R., and Mendez R. Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors. J. Viral Hepat. 12 (2005) 627-634
3. Coste J., Reesink H.W., Engelfriet C.P., Leperche S., Brown S., Busch M.P., Cuijpers H.T., Elgin R., Ekermo B., Epstein J.S., Flesland O., Heier H.E., Henn G., Hernandez J.M., Hewlett I.K., Hyland C., Keller A.J., Krusius T., Levičnik-Stezinar S., Levy G., Lin C.K., Margaritis A.R., Muylle L., Neiderhauser C., Pastila S., Pillonel J., Pineau J., Van der Poel C.L., Politis C., Roth W.K., Sauleda S., Seed C.R., Sondag-Thull D., Stramer S.L., Strong M., Vamvakas E.C., Velati C., Vesga M.A., and Zanetti A. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang. 88 (2005) 289-303
4. Dhumeaux D., Marcellin P., and Lerebours E. Treatment of hepatitis C. The 2002 French Consensus. Gut 52 (2003) 1784-1787
5. Halfon P., Bourliere M., Penaranda G., Khiri H., and Ouzan D. Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection. J. Clin. Microbiol. 44 (2006) 2507-2511
6. Jarvis L.M., Dow B.C., Cleland A., Davidson F., Lycett C., Morris K., Webb B., Jordan A., and Petrik J. Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing. Vox Sang. 89 (2005) 128-134
7. Khan N., Aswad S., Shidban H., Aghajani M., Mendez R., Mendez R., and Comanor L. Improved detection of HCV Infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center. J. Clin. Virol. 30 (2004) 175-182
8. Mine H., Emura H., Miyamoto M., Tomono T., Minegishi K., Murokawa H., Yamanaka R., Yoshikawa A., Nishioka K., and Japanese Red Cross NAT Research Group. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. J. Virol. Methods 112 (2003) 145-151
9. National Institutes of Health. National Institutes of Health consensus development conference statement: management of hepatitis C: 2002, June 10-12. Hepatology 36 Suppl. 1 (2002) S3-S20
10. Offergeld R., Faensen D., Ritter S., and Hamouda O. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing. Euro Surveill. 10 (2005) 8-11
11. Pawlotsky J.M. Use and interpretation of hepatitis C virus diagnostic assays. Clin. Liver Dis. 7 (2003) 127-137
12. Pillonel J., Laperche S., and Etablissement Francais du sang. Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT). Euro Surveill. 10 (2005) 5-8
13. Roth W.K., Weber M., Buhr S., Drosten C., Weichert W., Sireis W., Hedges D., and Seifried E. Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in Central Europe. Transfusion 42 (2002) 862-868
14. Seme K., Poljak M., Dovč P., and Koren S. Comparative evaluation of four genotyping methods for hepatitis C virus. Folia Biol. 43 (1997) 219-224
15. Simmonds P., Kurtz J., and Tedder R.S. The UK blood transfusion service: over a (patent) barrel?. Lancet 359 (2002) 1713-1714
16. Soldan K., Davison K., and Dow B. Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom 1996-2003. Euro Surveill. 10 (2005) 17-19
17. Strader D.B., Wright T., Thomas D.L., Seeff L.B., and American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology 39 (2004) 1147-1171
18. Stramer S.L., Glynn S.A., Kleinman S.H., Strong D.M., Caglioti S., Wright D.J., Dodd R.Y., Busch M.P., National Heart, Lung, and and Blood Institute Nucleic Acid Test Study Group. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N. Engl. J. Med. 351 (2004) 760-768
19. Trišler Z., Seme K., Poljak M., Čelan Lucu B., and Sakoman S. Prevalence of hepatitis C and G virus infections among intravenous drug users in Slovenia and Croatia. Scand. J. Infect. Dis. 31 (1999) 33-35
20. Van Beek I., Dwyer R., Dore G.J., Luo K., and Kaldor J.M. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. Br. Med. J. 317 (1998) 433-437